undamentalytics Newsletter

Hinge Health, Inc. income statement

In fiscal 2025, Hinge Health, Inc. reported revenue of $588m, up 50.6% on the year before, operating income of −$546m (a -92.9% margin) and net income of −$528m, or −$7.77 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Hinge Health, Inc.: income statement, annual
Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue293390588720
Cost of revenue9991120112
Gross profit194300468608
Research and development110101368129
Selling and marketing148167317273
General and administrative6764330112
Operating income−131−32−54694
Provision for credit losses5532
Income before tax−109−11−527111
Income tax−0112
Net income−108−12−528109
Diluted EPS−$2.08−$0.22−$7.77—
Diluted shares (average)52m54m55m—
EBITDA−125−26−54197

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: GDRX vs HNGEDOCS vs HNGEHNGE vs PHR

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Hinge Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Hinge Health, Inc.